2-(N'-alkylidenehydrazino)adenosines: potent and selective coronary vasodilators

Area of Science:

• Medicinal Chemistry
• Cardiovascular Pharmacology
• Organic Synthesis

Background:

• Adenosine receptors (A1AR and A2) play critical roles in regulating cardiac and coronary physiology.
• A1AR mediates negative chronotropic, dromotropic, and inotropic effects, while A2 receptors are involved in coronary vasodilation.

Purpose of the Study:

• To synthesize novel 2-(N extquotesingle-alkylidenehydrazino)-adenosine analogues.
• To evaluate the cardiovascular effects of these synthesized compounds, focusing on their impact on impulse conduction and coronary vasodilation.

Main Methods:

• Synthesis of 2-(N extquotesingle-alkylidenehydrazino)-adenosines (5-22) from aliphatic aldehydes/ketones and 2-hydrazinoadenosine.
• Bioassays using a guinea pig heart Langendorff preparation to assess negative dromotropic effects and coronary vasodilation.
• Pharmacological characterization using adenosine receptor antagonists.

Main Results:

• Several synthesized analogues exhibited potent coronary vasodilatory activity, with EC50s as low as 1 nM for n-pentylidene (8) and isopentylidene (18) congeners.
• Some analogues showed weak negative dromotropic effects on AV node impulse conduction.
• The coronary vasoactivity correlated with the length of the alkyl chain, and specific cyclohexyl-containing analogues were highly potent.

Conclusions:

• Novel 2-(N extquotesingle-alkylidenehydrazino)-adenosine derivatives represent a promising class of compounds for cardiovascular research, particularly as coronary vasodilators.
• The structure-activity relationship indicates that specific alkyl chain lengths and cyclohexyl substitutions enhance vasodilatory potency.
• These findings contribute to understanding adenosine receptor modulation in cardiovascular function.